Alphapharm has a total of 108 patents globally, out of which 43 have been granted. Of these 108 patents, more than 18% patents are active. Australia is where Alphapharm has filed the maximum number of patents, followed by Europe (EPO) and United States of America. Parallelly, Australia seems to be the main focused R&D centre and also is the origin country of Alphapharm.
Alphapharm was founded in 1982. Alphapharm pioneers in the pharmaceutical company, dedicated to advancing global healthcare through innovation. The company focus on oncology, neurology, cardiovascular health, and infectious diseases, offering a diverse range of high-quality medications.
Do read about some of the most popular patents of Alphapharm which have been covered by us in this article and also you can find Alphapharm patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Alphapharm patent portfolio.
How many patents does Alphapharm have?
Alphapharm has a total of 108 patents globally. These patents belong to 15 unique patent families. Out of 108 patents, 20 patents are active.
How Many Patents did Alphapharm File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Alphapharm Applications Filed | Alphapharm Patents Granted |
| 2017 | 1 | 2 |
| 2016 | 2 | 13 |
| 2015 | 1 | 9 |
| 2014 | 2 | 13 |
| 2013 | 10 | 4 |
| 2011 | 2 | – |
| 2010 | 2 | – |
| 2009 | 21 | 2 |
| 2008 | 27 | – |
| 2007 | 35 | – |
How many Alphapharm patents are Alive/Dead?
Worldwide Patents
How Many Patents did Alphapharm File in Different Countries?
Countries in which Alphapharm Filed Patents
| Country | Patent |
| Australia | 18 |
| Europe (EPO) | 13 |
| United States of America | 11 |
| Canada | 11 |
| Japan | 7 |
| India | 6 |
| China | 5 |
| New Zealand | 3 |
| Spain | 2 |
| Slovenia | 2 |
| Austria | 2 |
| Germany | 2 |
| Estonia | 2 |
| Malta | 2 |
| Portugal | 1 |
| South Africa | 1 |
| Slovakia | 1 |
| Croatia | 1 |
| Hungary | 1 |
| Poland | 1 |
| Cyprus | 1 |
| Denmark | 1 |
| Norway | 1 |
Where are Research Centers of Alphapharm Patents Located?
10 Best Alphapharm Patents
WO2008095263A1 is the most popular patent in the Alphapharm portfolio. It has received 32 citations so far from companies like Novartis, Omeros Corp, Eli Lilly.
Below is the list of 10 most cited patents of Alphapharm:
| Publication Number | Citation Count |
| WO2008095263A1 | 32 |
| US20150175282A1 | 20 |
| WO2008000040A1 | 17 |
| WO2007053904A1 | 16 |
| CN101939004A | 10 |
| WO2009049354A1 | 9 |
| WO2008074098A1 | 8 |
| WO2009026621A1 | 7 |
| WO2007121523A1 | 5 |
| US20110206770A1 | 4 |
What are Alphapharm key innovation segments?
What Technologies are Covered by Alphapharm?
The chart below distributes patents filed by Alphapharm in different countries on the basis of the technology protected in patents. It also represents the markets where Alphapharm thinks it’s important to protect particular technology inventions.
R&D Focus: How has Alphapharm search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!